T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques

Nicole Espy, Elyse Nagle, Brad Pfeffer, Karla Garcia, Alex J. Chitty, Michael R Wiley, Mariano Sanchez-Lockhart, Sina Bavari, Travis Warren, Gustavo Palacios

Research output: Contribution to journalArticle

Abstract

Nucleoside analogues (NA) disrupt RNA viral RNA-dependent RNA polymerase (RdRP) function and fidelity for multiple viral families. The mechanism of action (MOA) of T-705 has been attributed alternatively or concurrently to chain termination and lethal mutagenesis depending on the viral species during in vitro studies. In this study, we evaluated the effect of T-705 on the viral population in non-human primates (NHPs) after challenge with Ebola virus (EBOV) or Marburg virus (MARV) to identify the predominant in vivo MOA. We used common virological assays in conjunction with deep sequencing to characterize T-705 effects. T-705 exhibited antiviral activity that was associated with a reduction in specific infectivity and an accumulation of low frequency nucleotide variants in plasma samples collected day 7 post infection. Stranded analysis of deep sequencing data to identify chain termination demonstrated no change in the transcriptional gradient in negative stranded viral reads and minimal changes in positive stranded viral reads in T-705 treated animals, questioning as a MOA in vivo. These findings indicate that lethal mutagenesis is a MOA of T-705 that may serve as an indication of therapeutic activity of NAs for evaluation in clinical settings. This study expands our understanding of MOAs of these compounds for the Filovirus family and provides further evidence that lethal mutagenesis could be a preponderant MOA for this class of therapeutic compounds.

Original languageEnglish (US)
Article number104529
JournalAntiviral Research
Volume170
DOIs
StatePublished - Oct 1 2019

Fingerprint

Macaca
Mutagenesis
High-Throughput Nucleotide Sequencing
Marburgvirus
Ebolavirus
Population
RNA Replicase
Viral RNA
Nucleosides
Primates
Antiviral Agents
Nucleotides
RNA
Therapeutics
Infection

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Cite this

Espy, N., Nagle, E., Pfeffer, B., Garcia, K., Chitty, A. J., Wiley, M. R., ... Palacios, G. (2019). T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques. Antiviral Research, 170, [104529]. https://doi.org/10.1016/j.antiviral.2019.06.001

T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques. / Espy, Nicole; Nagle, Elyse; Pfeffer, Brad; Garcia, Karla; Chitty, Alex J.; Wiley, Michael R; Sanchez-Lockhart, Mariano; Bavari, Sina; Warren, Travis; Palacios, Gustavo.

In: Antiviral Research, Vol. 170, 104529, 01.10.2019.

Research output: Contribution to journalArticle

Espy, N, Nagle, E, Pfeffer, B, Garcia, K, Chitty, AJ, Wiley, MR, Sanchez-Lockhart, M, Bavari, S, Warren, T & Palacios, G 2019, 'T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques', Antiviral Research, vol. 170, 104529. https://doi.org/10.1016/j.antiviral.2019.06.001
Espy, Nicole ; Nagle, Elyse ; Pfeffer, Brad ; Garcia, Karla ; Chitty, Alex J. ; Wiley, Michael R ; Sanchez-Lockhart, Mariano ; Bavari, Sina ; Warren, Travis ; Palacios, Gustavo. / T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques. In: Antiviral Research. 2019 ; Vol. 170.
@article{6ccc03f5a89846c9806528431e3d9c00,
title = "T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques",
abstract = "Nucleoside analogues (NA) disrupt RNA viral RNA-dependent RNA polymerase (RdRP) function and fidelity for multiple viral families. The mechanism of action (MOA) of T-705 has been attributed alternatively or concurrently to chain termination and lethal mutagenesis depending on the viral species during in vitro studies. In this study, we evaluated the effect of T-705 on the viral population in non-human primates (NHPs) after challenge with Ebola virus (EBOV) or Marburg virus (MARV) to identify the predominant in vivo MOA. We used common virological assays in conjunction with deep sequencing to characterize T-705 effects. T-705 exhibited antiviral activity that was associated with a reduction in specific infectivity and an accumulation of low frequency nucleotide variants in plasma samples collected day 7 post infection. Stranded analysis of deep sequencing data to identify chain termination demonstrated no change in the transcriptional gradient in negative stranded viral reads and minimal changes in positive stranded viral reads in T-705 treated animals, questioning as a MOA in vivo. These findings indicate that lethal mutagenesis is a MOA of T-705 that may serve as an indication of therapeutic activity of NAs for evaluation in clinical settings. This study expands our understanding of MOAs of these compounds for the Filovirus family and provides further evidence that lethal mutagenesis could be a preponderant MOA for this class of therapeutic compounds.",
author = "Nicole Espy and Elyse Nagle and Brad Pfeffer and Karla Garcia and Chitty, {Alex J.} and Wiley, {Michael R} and Mariano Sanchez-Lockhart and Sina Bavari and Travis Warren and Gustavo Palacios",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.antiviral.2019.06.001",
language = "English (US)",
volume = "170",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques

AU - Espy, Nicole

AU - Nagle, Elyse

AU - Pfeffer, Brad

AU - Garcia, Karla

AU - Chitty, Alex J.

AU - Wiley, Michael R

AU - Sanchez-Lockhart, Mariano

AU - Bavari, Sina

AU - Warren, Travis

AU - Palacios, Gustavo

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Nucleoside analogues (NA) disrupt RNA viral RNA-dependent RNA polymerase (RdRP) function and fidelity for multiple viral families. The mechanism of action (MOA) of T-705 has been attributed alternatively or concurrently to chain termination and lethal mutagenesis depending on the viral species during in vitro studies. In this study, we evaluated the effect of T-705 on the viral population in non-human primates (NHPs) after challenge with Ebola virus (EBOV) or Marburg virus (MARV) to identify the predominant in vivo MOA. We used common virological assays in conjunction with deep sequencing to characterize T-705 effects. T-705 exhibited antiviral activity that was associated with a reduction in specific infectivity and an accumulation of low frequency nucleotide variants in plasma samples collected day 7 post infection. Stranded analysis of deep sequencing data to identify chain termination demonstrated no change in the transcriptional gradient in negative stranded viral reads and minimal changes in positive stranded viral reads in T-705 treated animals, questioning as a MOA in vivo. These findings indicate that lethal mutagenesis is a MOA of T-705 that may serve as an indication of therapeutic activity of NAs for evaluation in clinical settings. This study expands our understanding of MOAs of these compounds for the Filovirus family and provides further evidence that lethal mutagenesis could be a preponderant MOA for this class of therapeutic compounds.

AB - Nucleoside analogues (NA) disrupt RNA viral RNA-dependent RNA polymerase (RdRP) function and fidelity for multiple viral families. The mechanism of action (MOA) of T-705 has been attributed alternatively or concurrently to chain termination and lethal mutagenesis depending on the viral species during in vitro studies. In this study, we evaluated the effect of T-705 on the viral population in non-human primates (NHPs) after challenge with Ebola virus (EBOV) or Marburg virus (MARV) to identify the predominant in vivo MOA. We used common virological assays in conjunction with deep sequencing to characterize T-705 effects. T-705 exhibited antiviral activity that was associated with a reduction in specific infectivity and an accumulation of low frequency nucleotide variants in plasma samples collected day 7 post infection. Stranded analysis of deep sequencing data to identify chain termination demonstrated no change in the transcriptional gradient in negative stranded viral reads and minimal changes in positive stranded viral reads in T-705 treated animals, questioning as a MOA in vivo. These findings indicate that lethal mutagenesis is a MOA of T-705 that may serve as an indication of therapeutic activity of NAs for evaluation in clinical settings. This study expands our understanding of MOAs of these compounds for the Filovirus family and provides further evidence that lethal mutagenesis could be a preponderant MOA for this class of therapeutic compounds.

UR - http://www.scopus.com/inward/record.url?scp=85069721219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069721219&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2019.06.001

DO - 10.1016/j.antiviral.2019.06.001

M3 - Article

VL - 170

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

M1 - 104529

ER -